Potvin C consequences [Two-Stage / GS Designs]

posted by mittyri  – Russia, 2022-06-26 01:29 (1448 d 09:35 ago) – Posting: # 23087
Views: 7,919

Hi Helmut (and ElMaestro - sorry to post in this thread, but all your answers are great!),

❝ Of course, ElMaestro is right.

❝

There Can Be Only One.


OK, I understand the logic here.
take a look at some (theoretical) situation: a Sponsor goes with Potvin C (don't ask me why), moreover, he proved that with the current CV and n1 T1E does not exceed 5%.
But as you showed in the lectures and in example above, Potvin C could not ensure 5% for all combinations. Thus, during stage 1 the CV was lower and the resulted T1E was out of 5%.
What would be the right (safe) way out in such situation?
—
Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
124 visitors (0 registered, 124 guests [including 28 identified bots]).
Forum time: 11:05 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5